Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
US Department of Justice
Harvard Business School
Federal Trade Commission
Julphar
Chubb
Queensland Health
Accenture
Covington

Generated: May 24, 2018

DrugPatentWatch Database Preview

RAUTENSIN Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Rautensin, and what generic alternatives are available?

Rautensin is a drug marketed by Novartis and is included in one NDA.

The generic ingredient in RAUTENSIN is alseroxylon. Additional details are available on the alseroxylon profile page.
Summary for RAUTENSIN
Drug patent expirations by year for RAUTENSIN
Synonyms for RAUTENSIN
1, N-(2-aminoethyl)-N'-[2-[(2-aminoethyl)amino]ethyl]-, polymer with (chloromethyl)oxirane
1,2-Ethanediamine, N-(2-aminoethyl)-N'-(2-((2-aminoethyl)amino)ethyl)-, polymer with (chloromethyl)oxirane
1,2-Ethanediamine, N1-(2-aminoethyl)-N2-(2-((2-aminoethyl)amino)ethyl)-, polymer with 2-(chloromethyl)oxirane
11006-60-3
26658-42-4
50925-79-6
8001-95-4
AC1L1XU1
Alseroxylon
Alseroxylon [JAN]
C06925
Cholestabyl
COLESTIPOL
Colestipol [INN:BAN]
Colestipolum
Colestipolum [INN-Latin]
Copolymer of bis(2-aminoethyl)amine and 2-(chloromethyl)oxirane
DB00375
DR000988
Egalin
Epichlorohydrin-tetraethylenepentamine copolymer
Epichlorohydrin-tetraethylenepentamine polymer
Epichlorohydrin, polymer with tetraethylenepentamine
Epichlorohydrin, tetraethylenepentamine polymer
epichlorohydrin; tetraethylenepentamine
GMRWGQCZJGVHKL-UHFFFAOYSA-N
K50N755924
LP083058
LS-182744
N'-[2-[2-(2-aminoethylamino)ethylamino]ethyl]ethane-1,2-diamine; 2-(chloromethyl)oxirane
NSC 147003
NSC-147003
NSC147003
Oxirane, (chloromethyl)-, polymer with N-(2-aminoethyl)-N'-(2-((2-aminoethyl)amino)ethyl-1,2-ethanediamine
Oxirane, polymer with N-(2-aminoethyl)-N'-[2-[(2-aminoethyl)amino]ethyl]-1,2-ethanediamine
Poly(epichlorohydrin-co-tetraethylenepentamine)
Propane, 1-chloro-2,3-epoxy-, polymer with tetraethylenepentamine
Rau-Tab
SCHEMBL1649962
Tetraethylenepentamine epichlorohydrin polymer
Tetraethylenepentamine-epichlorohydrin copolymer
Tetraethylenepentamine-epichlorohydrin polymer
Tetraethylenepentamine, cross-linked with epichlorohydrin
Tetraethylenepentamine, polymer with 1-chloro-2,3-epoxypropane
Tetraethylenepentamine, polymer with 1-chloro-2,3-epoxypropane (8CI)
Tetraethylenepentamine,3-epoxypropane
U 26,597A
U 26597A
UNII-K50N755924

US Patents and Regulatory Information for RAUTENSIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis RAUTENSIN alseroxylon TABLET;ORAL 009215-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Argus Health
Chinese Patent Office
Medtronic
US Department of Justice
Cipla
Covington
Accenture
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.